TippingPoint Biosciences
Develops novel drug discovery platform to target epigenetic targets in pediatric brain cancer
$4.5MSeed
Role not disclosedFV
Freeflow Ventures
Activity from announced rounds
Activity in this selectionAI
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $8.2M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionSift Biosciences
Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases
$3.7MPre-Seed
Role not disclosed